AU783667B2 - Use of tiludronic acid and derivatives thereof in poultry for the preparation of a medicinal product for preventing and treating osteoporosis - Google Patents

Use of tiludronic acid and derivatives thereof in poultry for the preparation of a medicinal product for preventing and treating osteoporosis Download PDF

Info

Publication number
AU783667B2
AU783667B2 AU11141/01A AU1114101A AU783667B2 AU 783667 B2 AU783667 B2 AU 783667B2 AU 11141/01 A AU11141/01 A AU 11141/01A AU 1114101 A AU1114101 A AU 1114101A AU 783667 B2 AU783667 B2 AU 783667B2
Authority
AU
Australia
Prior art keywords
laying
bone
use according
osteoporosis
tiludronic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU11141/01A
Other languages
English (en)
Other versions
AU1114101A (en
Inventor
Thierry Bardon
Dominique Thibaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ceva Sante Animale SA
Original Assignee
Ceva Sante Animale SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale SA filed Critical Ceva Sante Animale SA
Publication of AU1114101A publication Critical patent/AU1114101A/en
Application granted granted Critical
Publication of AU783667B2 publication Critical patent/AU783667B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU11141/01A 2000-01-12 2001-01-10 Use of tiludronic acid and derivatives thereof in poultry for the preparation of a medicinal product for preventing and treating osteoporosis Ceased AU783667B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0000356A FR2803521B1 (fr) 2000-01-12 2000-01-12 Utilisation de l'acide tiludronique et de ses derives chez la volaille pour la preparation d'un medicament destine a prevenir et a traiter l'osteoporose
FR0000356 2000-01-12

Publications (2)

Publication Number Publication Date
AU1114101A AU1114101A (en) 2001-07-19
AU783667B2 true AU783667B2 (en) 2005-11-24

Family

ID=8845841

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11141/01A Ceased AU783667B2 (en) 2000-01-12 2001-01-10 Use of tiludronic acid and derivatives thereof in poultry for the preparation of a medicinal product for preventing and treating osteoporosis

Country Status (15)

Country Link
US (1) US6482809B1 (fr)
EP (1) EP1129714B1 (fr)
JP (1) JP2001199891A (fr)
AT (1) ATE306273T1 (fr)
AU (1) AU783667B2 (fr)
CZ (1) CZ2001135A3 (fr)
DE (1) DE60113895T2 (fr)
DK (1) DK1129714T3 (fr)
ES (1) ES2249396T3 (fr)
FR (1) FR2803521B1 (fr)
HU (1) HUP0100122A3 (fr)
IL (1) IL140839A0 (fr)
NZ (1) NZ509285A (fr)
SK (1) SK286583B6 (fr)
ZA (1) ZA200100289B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ301143B6 (cs) * 2005-03-10 2009-11-18 Koropecký@Igor Zpusob získávání koncentrovaného glycerolu a smesi vyšších mastných kyselin z glycerinové fáze, vznikající pri výrobe bionafty

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0950417A2 (fr) * 1998-02-23 1999-10-20 Pfizer Products Inc. Traitement d' anomalies du squelette
WO2000064516A1 (fr) * 1999-04-22 2000-11-02 Hydromed Sciences A Division Of Gp Strategies Corporation Administration regulee de bisphosphonates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5953894A (en) * 1992-12-23 1994-07-19 Merck & Co., Inc. Bisphosphonate/estrogen therapy for treating and preventing bone loss

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0950417A2 (fr) * 1998-02-23 1999-10-20 Pfizer Products Inc. Traitement d' anomalies du squelette
WO2000064516A1 (fr) * 1999-04-22 2000-11-02 Hydromed Sciences A Division Of Gp Strategies Corporation Administration regulee de bisphosphonates

Also Published As

Publication number Publication date
DE60113895T2 (de) 2006-06-22
ATE306273T1 (de) 2005-10-15
ZA200100289B (en) 2001-07-24
EP1129714A1 (fr) 2001-09-05
HUP0100122A3 (en) 2003-02-28
HUP0100122A2 (hu) 2002-03-28
AU1114101A (en) 2001-07-19
CZ2001135A3 (cs) 2001-08-15
US6482809B1 (en) 2002-11-19
EP1129714B1 (fr) 2005-10-12
DE60113895D1 (de) 2006-02-23
DK1129714T3 (da) 2006-02-06
FR2803521A1 (fr) 2001-07-13
NZ509285A (en) 2002-05-31
JP2001199891A (ja) 2001-07-24
FR2803521B1 (fr) 2002-10-25
HU0100122D0 (en) 2001-03-28
IL140839A0 (en) 2002-02-10
SK552001A3 (en) 2001-08-06
ES2249396T3 (es) 2006-04-01
SK286583B6 (sk) 2009-01-07

Similar Documents

Publication Publication Date Title
AU686628B2 (en) Parathyroid Hormone and Raloxifene for Increasing Bone Mass
JP3062001B2 (ja) 骨修復を促進することを意図した医薬組成物の調製のためのビスホスホン酸誘導体の使用および対応する医薬組成物
EP1294384B1 (fr) Traitement des maladies osseuses avec le lanthane
AU2001274341A1 (en) Use of lanthanum compounds for the treatment of bone diseases
Brown et al. Safety and efficacy of intravenous zoledronic acid in paediatric osteoporosis
AU783667B2 (en) Use of tiludronic acid and derivatives thereof in poultry for the preparation of a medicinal product for preventing and treating osteoporosis
US20060183717A1 (en) Process for treating lameness with an osseous, articular or osteoarticular component in human or veterinary medicine, comprising the administration of a bisphosphonic acid derivative
AU782895B2 (en) Process for increasing the egg production and strengthening the eggshells of poultry
JP2001199891A5 (fr)
KR20220032874A (ko) 2,4,6-트리페닐-1-헥센을 유효성분으로 포함하는 골질환 예방 또는 치료용 조성물
Lombardi et al. Oral Alendronate in the Treatment of Postmenopausal Osteoporosis